TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
Yuan Y, He W, Yang Z, Qiu J, Huang Z, Shi Y, Lin Z, Zheng Y, Chen M, Lau WY, Li B, Yuan Y.
Int J Surg. 2023 May 1;109(5):1222-1230. doi: 10.1097/JS9.0000000000000256.
PMID:37026861
Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.